Announce Date | 02/05/2025 |
EPS Normalized Actual | $3.21 (Beat by $2.71) |
EPS GAAP Actual | $3.21 (Beat by $2.71) |
Revenue Actual | $1.529B |
Revenue Surprise | Beat by $1529M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.48154 |
EPS GAAP Estimate | $0.48154 |
Revenue Estimate | $12.501156723B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 6.19 | 11.46 | 5.78448 | 6.50434 | 10 |
Dec 2028 | 4.484 | 15.82 | 4.17171 | 4.66748 | 14 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2017 (Mar 2017) | -0.55 | -0.55 | 1.529B | 100% | 1529M |
FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 1.813B | 100% | 1813M |
FQ3 2017 (Sep 2017) | -0.84 | -0.84 | 2.149B | 100% | 2149M |
FQ4 2017 (Dec 2017) | -0.38 | -0.38 | 2.441B | 100% | 2441M |
FQ4 2024 (Dec 2024) | 3.27 | 3.27 | 11.959B | 16.92% | 11959M |
FQ3 2024 (Sep 2024) | 1.24 | 1.24 | 11.188B | 16.95% | 11188M |
FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 10.7B | 13.74% | 10700M |
FQ1 2024 (Mar 2024) | -0.31 | -0.31 | 10.131B | 12.91% | 10131M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.48154
Consensus Revenue Estimates
12.501156723B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.05 | -- | 1.01606 | 1.08001 | 9 |
FQ2 2027 (Jun 2027) | 0.98 | -- | 0.94833 | 1.00801 | 9 |
FQ1 2027 (Mar 2027) | 0.95 | -- | 0.9144 | 0.97908 | 11 |
FQ4 2026 (Oct 2026) | 0.74 | -- | 0.69704 | 0.78518 | 9 |
FQ3 2026 (Jul 2026) | 0.7 | -- | 0.65937 | 0.74274 | 9 |
FQ2 2026 (Jun 2026) | 0.7 | -- | 0.61167 | 0.75787 | 9 |
FQ1 2026 (Mar 2026) | 0.67 | -- | 0.58546 | 0.72539 | 9 |
FQ4 2025 (Oct 2025) | 0.55097 | -493.5 | 0.51899 | 0.58461 | 10 |
FQ3 2025 (Jul 2025) | 0.50396 | -146.05 | 0.47471 | 0.53473 | 10 |
FQ2 2025 (Jun 2025) | 0.48154 | -1.76 | 0.42078 | 0.52135 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 26.61B | -- | 25.95B | 27.19B | 11 |
FQ2 2027 (Jun 2027) | 24.74B | -- | 24.13B | 25.29B | 8 |
FQ1 2027 (Mar 2027) | 15.27B | -- | 14.83B | 15.63B | 12 |
FQ4 2026 (Oct 2026) | 14.33B | -- | 13.69B | 15B | 12 |
FQ3 2026 (Jul 2026) | 14.04B | -- | 13.41B | 14.69B | 22 |
FQ2 2026 (Jun 2026) | 14.05B | -- | 12.68B | 14.94B | 22 |
FQ1 2026 (Mar 2026) | 13.31B | -- | 12.02B | 14.15B | 12 |
FQ4 2025 (Oct 2025) | 12.78B | 6.46 | 12.21B | 13.39B | 17 |
FQ3 2025 (Jul 2025) | 12.51B | 10.54 | 11.95B | 13.09B | 11 |
FQ2 2025 (Jun 2025) | 12.5B | 14.41 | 11.29B | 13.3B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2017 (Mar 2017) | -0.55 | -0.55 | 100% | |
FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 100% | |
FQ3 2017 (Sep 2017) | -0.84 | -0.84 | 100% | |
FQ4 2017 (Dec 2017) | -0.38 | -0.38 | 100% | |
FQ4 2024 (Dec 2024) | 3.27 | 3.27 | 100% | |
FQ3 2024 (Sep 2024) | 1.24 | 1.24 | 100% | |
FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 100% | |
FQ1 2024 (Mar 2024) | -0.31 | -0.31 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2017 (Mar 2017) | $0B | $1.53B | $1529M | 100% |
FQ2 2017 (Jun 2017) | $0B | $1.81B | $1813M | 100% |
FQ3 2017 (Sep 2017) | $0B | $2.15B | $2149M | 100% |
FQ4 2017 (Dec 2017) | $0B | $2.44B | $2441M | 100% |
FQ4 2024 (Dec 2024) | $0B | $11.96B | $11959M | 100% |
FQ3 2024 (Sep 2024) | $0B | $11.19B | $11188M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.7B | $10700M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.13B | $10131M | 100% |